| Year |
Citation |
Score |
| 2024 |
Shi Y, Zhang J, Xiu M, Xie R, Liu Y, Xie J, Shi L. The zona incerta system: Involvement in Parkinson's disease. Experimental Neurology. 114992. PMID 39393673 DOI: 10.1016/j.expneurol.2024.114992 |
0.367 |
|
| 2024 |
Duan J, Lv A, Guo Z, Liu Q, Tian C, Yang Y, Bi J, Yu X, Peng G, Luo B, Cai Z, Xu B, Fu Y, Zhang J. CX3CR1/UCHL1 microglial extracellular vesicles in blood: a potential biomarker for multiple sclerosis. Journal of Neuroinflammation. 21: 254. PMID 39385200 DOI: 10.1186/s12974-024-03243-z |
0.337 |
|
| 2024 |
Zhang J, Shi M, Zhang Q, Chen Y, Yin X, Wang X, Zhang Y. Association between constipation and the risk of Parkinson's disease among participants in the UK Biobank. Neuroepidemiology. PMID 39159603 DOI: 10.1159/000540955 |
0.357 |
|
| 2024 |
Lian B, Zhang J, Yin X, Wang J, Li L, Ju Q, Wang Y, Jiang Y, Liu X, Chen Y, Tang X, Sun C. SIRT1 improves lactate homeostasis in the brain to alleviate parkinsonism via deacetylation and inhibition of PKM2. Cell Reports. Medicine. 101684. PMID 39128469 DOI: 10.1016/j.xcrm.2024.101684 |
0.357 |
|
| 2024 |
Yang Y, Nie X, Wang Y, Sun J, Gao X, Zhang J. Evolving insights into erythrocytes in synucleinopathies. Trends in Neurosciences. PMID 39043489 DOI: 10.1016/j.tins.2024.06.005 |
0.389 |
|
| 2024 |
Zhang Q, Shi M, Zhang J, Yin X, Chen Y, Wang X, Zhang Y. Association between physical activity and Parkinson's disease: A prospective cohort study. Neuroepidemiology. PMID 39038446 DOI: 10.1159/000540397 |
0.326 |
|
| 2024 |
LoPiccolo MK, Wang Z, Eshed GM, Fierro L, Stauffer C, Wang K, Zhang J, Tatsuoka C, Balwani M, Zou WQ, Alcalay RN. Skin α-Synuclein Seeding Activity in Patients with Type 1 Gaucher Disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 39021250 DOI: 10.1002/mds.29935 |
0.368 |
|
| 2024 |
Tong B, Ba Y, Li Z, Yang C, Su K, Qi H, Zhang D, Liu X, Wu Y, Chen Y, Ling J, Zhang J, Yu P, Yin X. Targeting dysregulated lipid metabolism for the treatment of Alzheimer's disease and Parkinson's disease: Current advancements and future prospects. Neurobiology of Disease. 106505. PMID 38642715 DOI: 10.1016/j.nbd.2024.106505 |
0.365 |
|
| 2024 |
Li H, Zhang J, Shen Y, Ye Y, Jiang Q, Chen L, Sun B, Chen Z, Shen L, Fang H, Yang J, Gu H. Targeting Mitochondrial Complex I Deficiency in MPP/MPTP-induced Parkinson's Disease Cell Culture and Mouse Models by Transducing Yeast NDI1 Gene. Biological Procedures Online. 26: 9. PMID 38594619 DOI: 10.1186/s12575-024-00236-3 |
0.337 |
|
| 2023 |
Yang Y, Stewart T, Zhang C, Wang P, Xu Z, Jin J, Huang Y, Liu Z, Lan G, Liang X, Sheng L, Shi M, Cai Z, Zhang J. Erythrocytic α-Synuclein and the Gut Microbiome: Kindling of the Gut-Brain Axis in Parkinson's Disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 37798868 DOI: 10.1002/mds.29620 |
0.826 |
|
| 2023 |
Yang Y, Shi PhD M, Liu X, Zhu Q, Xu Z, Liu G, Feng T, Stewart T, Zhang J. Calcium Influx: An Essential Process by which α-Synuclein Regulates Morphology of Erythrocytes. Journal of Advanced Research. PMID 37714326 DOI: 10.1016/j.jare.2023.09.009 |
0.368 |
|
| 2023 |
Le Guen Y, Luo G, Ambati A, Damotte V, Jansen I, Yu E, Nicolas A, de Rojas I, Peixoto Leal T, Miyashita A, Bellenguez C, Lian MM, Parveen K, Morizono T, Park H, ... ... Zhang J, et al. Multiancestry analysis of the HLA locus in Alzheimer's and Parkinson's diseases uncovers a shared adaptive immune response mediated by subtypes. Proceedings of the National Academy of Sciences of the United States of America. 120: e2302720120. PMID 37643212 DOI: 10.1073/pnas.2302720120 |
0.367 |
|
| 2023 |
Wang P, Lan G, Xu B, Yu Z, Tian C, Lei X, Meissner WG, Feng T, Yang Y, Zhang J. α-Synuclein-carrying astrocytic extracellular vesicles in Parkinson pathogenesis and diagnosis. Translational Neurodegeneration. 12: 40. PMID 37620916 DOI: 10.1186/s40035-023-00372-y |
0.357 |
|
| 2023 |
Yu Z, Yang Y, Chan RB, Shi M, Stewart T, Huang Y, Liu Z, Lan G, Sheng L, Tian C, Yang D, Zhang J. GV-971 attenuates α-Synuclein aggregation and related pathology. Cns Neuroscience & Therapeutics. PMID 37563872 DOI: 10.1111/cns.14393 |
0.825 |
|
| 2023 |
Liu Z, Huang Y, Wang X, Li JY, Zhang C, Yang Y, Zhang J. The cervical lymph node contributes to peripheral inflammation related to Parkinson's disease. Journal of Neuroinflammation. 20: 93. PMID 37038192 DOI: 10.1186/s12974-023-02770-5 |
0.343 |
|
| 2022 |
Zhang J. Investigating neurological symptoms of infectious diseases like COVID-19 leading to a deeper understanding of neurodegenerative disorders such as Parkinson's disease. Frontiers in Neurology. 13: 968193. PMID 36570463 DOI: 10.3389/fneur.2022.968193 |
0.367 |
|
| 2022 |
Ren M, Yang Y, Heng KHY, Ng LY, Chong CY, Ng YT, Gorur-Shandilya S, Lee RMQ, Lim KL, Zhang J, Koh TW. MED13 and glycolysis are conserved modifiers of α-synuclein-associated neurodegeneration. Cell Reports. 41: 111852. PMID 36543134 DOI: 10.1016/j.celrep.2022.111852 |
0.322 |
|
| 2022 |
Xu F, Zou XW, Yang LQ, Mo SC, Guo QH, Zhang J, Weng X, Xing GG. Facial muscle movements in patients with Parkinson's disease undergoing phonation tests. Frontiers in Neurology. 13: 1018362. PMID 36388198 DOI: 10.3389/fneur.2022.1018362 |
0.342 |
|
| 2022 |
Li J, Zhao J, Chen L, Gao H, Zhang J, Wang D, Zou Y, Qin Q, Qu Y, Li J, Xiong Y, Min Z, Yan M, Mao Z, Xue Z. α-Synuclein induces Th17 differentiation and impairs the function and stability of Tregs by promoting RORC transcription in Parkinson's disease. Brain, Behavior, and Immunity. PMID 36343753 DOI: 10.1016/j.bbi.2022.10.023 |
0.341 |
|
| 2022 |
Kong Y, Chen Z, Wang X, Wang W, Zhang J. Diagnostic Utility of Cerebrospinal Fluid α-Synuclein in Creutzfeldt-Jakob Disease: A Systematic Review and Meta-Analysis. Journal of Alzheimer's Disease : Jad. PMID 35912746 DOI: 10.3233/JAD-220425 |
0.327 |
|
| 2022 |
Tian C, Stewart T, Hong Z, Guo Z, Aro P, Soltys D, Pan C, Peskind ER, Zabetian CP, Shaw LM, Galasko D, Quinn JF, Shi M, Zhang J. Blood extracellular vesicles carrying synaptic function- and brain-related proteins as potential biomarkers for Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 35779041 DOI: 10.1002/alz.12723 |
0.316 |
|
| 2022 |
Huang Y, Liu Z, Li N, Tian C, Yang H, Huo Y, Li Y, Zhang J, Yu Z. Parkinson's disease derived exosomes aggravate neuropathology in SNCA*A53T mice. Annals of Neurology. PMID 35596947 DOI: 10.1002/ana.26421 |
0.392 |
|
| 2022 |
Li H, Sun B, Huang Y, Zhang J, Xu X, Shen Y, Chen Z, Yang J, Shen L, Hu Y, Gu H. Gene therapy of yeast NDI1 on mitochondrial complex I dysfunction in rotenone-induced Parkinson's disease models in vitro and vivo. Molecular Medicine (Cambridge, Mass.). 28: 29. PMID 35255803 DOI: 10.1186/s10020-022-00456-x |
0.332 |
|
| 2022 |
Liu Z, Chan RB, Cai Z, Liu X, Wu Y, Yu Z, Feng T, Yang Y, Zhang J. α-Synuclein-containing erythrocytic extracellular vesicles: essential contributors to hyperactivation of monocytes in Parkinson's disease. Journal of Neuroinflammation. 19: 53. PMID 35193594 DOI: 10.1186/s12974-022-02413-1 |
0.388 |
|
| 2022 |
Yang Y, Zhang S, Guan J, Jiang Y, Zhang J, Luo L, Sun C. SIRT1 attenuates neuroinflammation by deacetylating HSPA4 in a mouse model of Parkinson's disease. Biochimica Et Biophysica Acta. Molecular Basis of Disease. 166365. PMID 35158021 DOI: 10.1016/j.bbadis.2022.166365 |
0.33 |
|
| 2022 |
Zhang J. Mining imaging and clinical data with machine learning approaches for the diagnosis and early detection of Parkinson's disease. Npj Parkinson's Disease. 8: 13. PMID 35064123 DOI: 10.1038/s41531-021-00266-8 |
0.303 |
|
| 2022 |
Zhang J, Sun B, Yang J, Chen Z, Li Z, Zhang N, Li H, Shen L. Comparison of the effect of rotenone and 1‑methyl‑4‑phenyl‑1,2,3,6‑tetrahydropyridine on inducing chronic Parkinson's disease in mouse models. Molecular Medicine Reports. 25. PMID 35039876 DOI: 10.3892/mmr.2022.12607 |
0.334 |
|
| 2021 |
Lan G, Wang P, Chan RB, Liu Z, Yu Z, Liu X, Yang Y, Zhang J. Astrocytic VEGFA: An essential mediator in blood-brain-barrier disruption in Parkinson's disease. Glia. PMID 34713920 DOI: 10.1002/glia.24109 |
0.382 |
|
| 2021 |
Hu X, Zhang J, Qiu Y, Liu Z. Periodontal disease and the risk of Alzheimer's disease and mild cognitive impairment: a systematic review and meta-analysis. Psychogeriatrics : the Official Journal of the Japanese Psychogeriatric Society. PMID 34247432 DOI: 10.1111/psyg.12743 |
0.331 |
|
| 2021 |
Hong Z, Tian C, Stewart T, Aro P, Soltys D, Bercow M, Sheng L, Borden K, Khrisat T, Pan C, Zabetian CP, Peskind ER, Quinn JF, Montine TJ, Aasly J, ... ... Zhang J, et al. Development of a Sensitive Diagnostic Assay for Parkinson Disease Quantifying α-Synuclein-Containing Extracellular Vesicles. Neurology. 96: e2332-e2345. PMID 34032594 DOI: 10.1212/WNL.0000000000011853 |
0.817 |
|
| 2021 |
Li B, Yang Y, Wang Y, Zhang J, Ding J, Liu X, Jin Y, Lian B, Ling Y, Sun C. Acetylation of NDUFV1 induced by a newly synthesized HDAC6 inhibitor HGC rescues dopaminergic neuron loss in Parkinson models. Iscience. 24: 102302. PMID 33851105 DOI: 10.1016/j.isci.2021.102302 |
0.328 |
|
| 2021 |
Niu Y, Zhang J, Dong M. Nrf2 as a potential target for Parkinson's disease therapy. Journal of Molecular Medicine (Berlin, Germany). PMID 33844027 DOI: 10.1007/s00109-021-02071-5 |
0.357 |
|
| 2021 |
Liu X, Wang Q, Yang Y, Stewart T, Shi M, Soltys D, Liu G, Thorland E, Cilento EM, Hou Y, Liu Z, Feng T, Zhang J. Reduced erythrocytic CHCHD2 mRNA is associated with brain pathology of Parkinson's disease. Acta Neuropathologica Communications. 9: 37. PMID 33685516 DOI: 10.1186/s40478-021-01133-6 |
0.383 |
|
| 2020 |
Gao X, Huang Z, Feng C, Guan C, Li R, Xie H, Chen J, Li M, Que R, Deng B, Cao P, Li M, Lu J, Huang Y, Li M, ... ... Zhang J, et al. Multimodal analysis of gene expression from postmortem brains and blood identifies synaptic vesicle trafficking genes to be associated with Parkinson's disease. Briefings in Bioinformatics. PMID 33079984 DOI: 10.1093/bib/bbaa244 |
0.334 |
|
| 2020 |
Li N, Stewart T, Sheng L, Shi M, Cilento EM, Wu Y, Hong JS, Zhang J. Immunoregulation of microglial polarization: an unrecognized physiological function of α-synuclein. Journal of Neuroinflammation. 17: 272. PMID 32943057 DOI: 10.1186/S12974-020-01940-Z |
0.8 |
|
| 2020 |
Sheng L, Stewart T, Yang D, Thorland E, Soltys D, Aro P, Khrisat T, Xie Z, Li N, Liu Z, Tian C, Bercow M, Matsumoto J, Zabetian CP, Peskind E, ... ... Zhang J, et al. Erythrocytic α-synuclein contained in microvesicles regulates astrocytic glutamate homeostasis: a new perspective on Parkinson's disease pathogenesis. Acta Neuropathologica Communications. 8: 102. PMID 32641150 DOI: 10.1186/S40478-020-00983-W |
0.818 |
|
| 2020 |
Yu Z, Shi M, Stewart T, Fernagut PO, Huang Y, Tian C, Dehay B, Atik A, Yang D, De Giorgi F, Ichas F, Canron MH, Ceravolo R, Frosini D, Kim HJ, ... ... Zhang J, et al. Reduced oligodendrocyte exosome secretion in multiple system atrophy involves SNARE dysfunction. Brain : a Journal of Neurology. PMID 32428221 DOI: 10.1093/Brain/Awaa110 |
0.482 |
|
| 2020 |
Dong Y, Stewart T, Bai L, Li X, Xu T, Iliff J, Shi M, Zheng D, Yuan L, Wei T, Yang X, Zhang J. Coniferaldehyde attenuates Alzheimer's pathology activation of Nrf2 and its targets. Theranostics. 10: 179-200. PMID 31903114 DOI: 10.7150/Thno.36722 |
0.362 |
|
| 2019 |
Parada CA, Osbun JW, Busald T, Karasozen Y, Kaur S, Shi M, Barber J, Adidharma W, Cimino PJ, Pan C, Gonzalez-Cuyar LF, Rostomily R, Born DE, Zhang J, Ferreira M. Phosphoproteomic and Kinomic Signature of Clinically Aggressive Grade I (1.5) Meningiomas Reveals Rb1 signaling as a Novel Mediator and Biomarker. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 31615938 DOI: 10.1158/1078-0432.Ccr-18-0641 |
0.564 |
|
| 2019 |
Shaffer RM, Sheppard L, Peskind ER, Zhang J, Adar SD, Li G. Fine Particulate Matter Exposure and Cerebrospinal Fluid Markers of Vascular Injury. Journal of Alzheimer's Disease : Jad. PMID 31476158 DOI: 10.3233/JAD-190563 |
0.339 |
|
| 2019 |
Li N, Wu Y, Zhu L, Huang Y, Liu Z, Shi M, Soltys D, Zhang J, Chang Q. Extracellular microvesicles-derived from microglia treated with unaggregated α-synuclein attenuate mitochondrial fission and toxicity-induced by Parkinsonian toxin MPP. Biochemical and Biophysical Research Communications. PMID 31402119 DOI: 10.1016/j.bbrc.2019.07.084 |
0.467 |
|
| 2019 |
Fan W, Guo J, Gao B, Zhang W, Ling L, Xu T, Pan C, Li L, Chen S, Wang H, Zhang J, Wang X. Flotillin-mediated endocytosis and ALIX-syntenin-1-mediated exocytosis protect the cell membrane from damage caused by necroptosis. Science Signaling. 12. PMID 31138766 DOI: 10.1126/Scisignal.Aaw3423 |
0.303 |
|
| 2019 |
Tian C, Liu G, Gao L, Soltys D, Pan C, Stewart T, Shi M, Xie Z, Liu N, Feng T, Zhang J. Erythrocytic α-Synuclein as a potential biomarker for Parkinson's disease. Translational Neurodegeneration. 8: 15. PMID 31123587 DOI: 10.1186/S40035-019-0155-Y |
0.463 |
|
| 2019 |
Stewart T, Shi M, Mehrotra A, Aro P, Soltys D, Kerr KF, Zabetian CP, Peskind ER, Taylor P, Shaw LM, Trojanowski JQ, Zhang J. Impact of Pre-Analytical Differences on Biomarkers in the ADNI and PPMI Studies: Implications in the Era of Classifying Disease Based on Biomarkers. Journal of Alzheimer's Disease : Jad. PMID 30958379 DOI: 10.3233/Jad-190069 |
0.421 |
|
| 2019 |
Shi M, Sheng L, Stewart T, Zabetian CP, Zhang J. New windows into the brain: Central nervous system-derived extracellular vesicles in blood. Progress in Neurobiology. PMID 30685501 DOI: 10.1016/J.Pneurobio.2019.01.005 |
0.776 |
|
| 2018 |
Cao Z, Wu Y, Liu G, Jiang Y, Wang X, Wang Z, Zhang J, Feng T. α-synuclein in salivary extracellular vesicles as a potential biomarker of Parkinson's disease. Neuroscience Letters. PMID 30579996 DOI: 10.1016/j.neulet.2018.12.030 |
0.333 |
|
| 2018 |
Cilento EM, Jin L, Stewart T, Shi M, Sheng L, Zhang J. Mass Spectrometry: A Platform for Biomarker Discovery and Validation for Alzheimer's and Parkinson's Diseases. Journal of Neurochemistry. PMID 30474862 DOI: 10.1111/Jnc.14635 |
0.83 |
|
| 2018 |
Dong Y, Stewart T, Zhang Y, Shi M, Tan C, Li X, Yuan L, Mehrota A, Zhang J, Yang X. Anti-diabetic vanadyl complexes reduced Alzheimer's disease pathology independent of amyloid plaque deposition. Science China. Life Sciences. PMID 30136058 DOI: 10.1007/S11427-018-9350-1 |
0.348 |
|
| 2018 |
Mollenhauer B, DuBois BF, Drake D, Duong J, Blennow K, El-Agnaf O, Shaw LM, Masucci J, Taylor P, Umek RM, Dunty IM, Smith CL, Stoops E, Vanderstichele H, Schmid AW, ... ... Zhang J, et al. Antibody-based methods for the measurement of α-synuclein concentration in human cerebrospinal fluid - method comparison and round robin study. Journal of Neurochemistry. PMID 30125936 DOI: 10.1111/Jnc.14569 |
0.374 |
|
| 2018 |
Chen-Plotkin AS, Albin R, Alcalay R, Babcock D, Bajaj V, Bowman D, Buko A, Cedarbaum J, Chelsky D, Cookson MR, Dawson TM, Dewey R, Foroud T, Frasier M, German D, ... ... Zhang J, et al. Finding useful biomarkers for Parkinson's disease. Science Translational Medicine. 10. PMID 30111645 DOI: 10.1126/Scitranslmed.Aam6003 |
0.454 |
|
| 2018 |
Wang H, Atik A, Stewart T, Ginghina C, Aro P, Kerr KF, Seibyl J, Jennings D, Jensen PH, Marek K, Shi M, Zhang J. Plasma α-synuclein and cognitive impairment in the Parkinson's Associated Risk Syndrome: A pilot study. Neurobiology of Disease. PMID 29705185 DOI: 10.1016/J.Nbd.2018.04.015 |
0.436 |
|
| 2018 |
Shi M, Tang L, Toledo JB, Ginghina C, Wang H, Aro P, Jensen PH, Weintraub D, Chen-Plotkin AS, Irwin DJ, Grossman M, McCluskey L, Elman LB, Wolk DA, Lee EB, ... ... Zhang J, et al. Cerebrospinal fluid α-synuclein contributes to the differential diagnosis of Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 29604263 DOI: 10.1016/J.Jalz.2018.02.015 |
0.422 |
|
| 2018 |
Liu SY, Wile DJ, Fu JF, Valerio J, Shahinfard E, McCormick S, Mabrouk R, Vafai N, McKenzie J, Neilson N, Perez-Soriano A, Arena JE, Cherkasova M, Chan P, Zhang J, et al. The effect of LRRK2 mutations on the cholinergic system in manifest and premanifest stages of Parkinson's disease: a cross-sectional PET study. The Lancet. Neurology. PMID 29456161 DOI: 10.1016/S1474-4422(18)30032-2 |
0.424 |
|
| 2018 |
Parada CA, Osbun J, Kaur S, Yakkioui Y, Shi M, Pan C, Busald T, Karasozen Y, Gonzalez-Cuyar LF, Rostomily R, Zhang J, Ferreira M. Kinome and phosphoproteome of high-grade meningiomas reveal AKAP12 as a central regulator of aggressiveness and its possible role in progression. Scientific Reports. 8: 2098. PMID 29391485 DOI: 10.1038/s41598-018-19308-y |
0.301 |
|
| 2018 |
Wang H, Stewart T, Toledo JB, Ginghina C, Tang L, Atik A, Aro P, Shaw LM, Trojanowski JQ, Galasko DR, Edland S, Jensen PH, Shi M, Zhang J. A Longitudinal Study of Total and Phosphorylated α-Synuclein with Other Biomarkers in Cerebrospinal Fluid of Alzheimer's Disease and Mild Cognitive Impairment. Journal of Alzheimer's Disease : Jad. 61: 1541-1553. PMID 29376878 DOI: 10.3233/Jad-171013 |
0.391 |
|
| 2018 |
Yu Z, Stewart T, Aasly J, Shi M, Zhang J. Combining clinical and biofluid markers for early Parkinson's disease detection. Annals of Clinical and Translational Neurology. 5: 109-114. PMID 29376098 DOI: 10.1002/Acn3.509 |
0.479 |
|
| 2017 |
Matsumoto J, Stewart T, Banks WA, Zhang J. The transport mechanism of extracellular vesicles at the blood-brain barrier. Current Pharmaceutical Design. PMID 28914201 DOI: 10.2174/1381612823666170913164738 |
0.324 |
|
| 2017 |
Matsumoto J, Stewart T, Sheng L, Li N, Bullock K, Song N, Shi M, Banks WA, Zhang J. Transmission of α-synuclein-containing erythrocyte-derived extracellular vesicles across the blood-brain barrier via adsorptive mediated transcytosis: another mechanism for initiation and progression of Parkinson's disease? Acta Neuropathologica Communications. 5: 71. PMID 28903781 DOI: 10.1186/S40478-017-0470-4 |
0.817 |
|
| 2017 |
Mollenhauer B, Batrla R, El-Agnaf O, Galasko DR, Lashuel HA, Merchant KM, Shaw LM, Selkoe DJ, Umek R, Vanderstichele H, Zetterberg H, Zhang J, Caspell-Garcia C, Coffey C, Hutten SJ, et al. A user's guide for α-synuclein biomarker studies in biological fluids: Perianalytical considerations. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 28734051 DOI: 10.1002/Mds.27090 |
0.47 |
|
| 2017 |
Song N, Wang W, Jia F, Du X, Xie A, He Q, Shen X, Zhang J, Rogers JT, Xie J, Jiang H. Assessments of plasma ghrelin levels in the early stages of parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 28681931 DOI: 10.1002/Mds.27095 |
0.446 |
|
| 2017 |
Li G, Shofer JB, Petrie EC, Yu CE, Wilkinson CW, Figlewicz DP, Shutes-David A, Zhang J, Montine TJ, Raskind MA, Quinn JF, Galasko DR, Peskind ER. Cerebrospinal fluid biomarkers for Alzheimer's and vascular disease vary by age, gender, and APOE genotype in cognitively normal adults. Alzheimer's Research & Therapy. 9: 48. PMID 28673336 DOI: 10.1186/S13195-017-0271-9 |
0.517 |
|
| 2017 |
Gwinn K, David KK, Swanson-Fischer C, Albin R, Hillaire-Clarke CS, Sieber BA, Lungu C, Bowman FD, Alcalay RN, Babcock D, Dawson TM, Dewey RB, Foroud T, German D, Huang X, ... ... Zhang J, et al. Parkinson's disease biomarkers: perspective from the NINDS Parkinson's Disease Biomarkers Program. Biomarkers in Medicine. PMID 28644039 DOI: 10.2217/Bmm-2016-0370 |
0.491 |
|
| 2017 |
Wile DJ, Agarwal PA, Schulzer M, Mak E, Dinelle K, Shahinfard E, Vafai N, Hasegawa K, Zhang J, McKenzie J, Neilson N, Strongosky A, Uitti RJ, Guttman M, Zabetian CP, et al. Serotonin and dopamine transporter PET changes in the premotor phase of LRRK2 parkinsonism: cross-sectional studies. The Lancet. Neurology. PMID 28336296 DOI: 10.1016/S1474-4422(17)30056-X |
0.377 |
|
| 2017 |
Yang L, Stewart T, Shi M, Pottiez G, Dator R, Wu R, Aro P, Schuster RJ, Ginghina C, Pan C, Gao Y, Qian W, Zabetian CP, Hu SC, Quinn JF, ... Zhang J, et al. An alpha-synuclein MRM assay with diagnostic potential for Parkinson's disease and monitoring disease progression. Proteomics. Clinical Applications. PMID 28319654 DOI: 10.1002/Prca.201700045 |
0.486 |
|
| 2017 |
Pottiez G, Yang L, Stewart T, Song N, Aro P, Galasko D, Quinn J, Peskind E, Shi M, Zhang J. A mass spectrometry-based method to quantify in parallel Tau and amyloid β 1-42 in CSF for the diagnostic of Alzheimer's Disease. Journal of Proteome Research. PMID 28112948 DOI: 10.1021/Acs.Jproteome.6B00829 |
0.368 |
|
| 2016 |
Banks WA, Kovac A, Majerova P, Bullock KM, Shi M, Zhang J. Tau Proteins Cross the Blood-Brain Barrier. Journal of Alzheimer's Disease : Jad. PMID 27662303 DOI: 10.3233/JAD-160542 |
0.383 |
|
| 2016 |
Zhang J, Wang X, Li J, Huang R, Yu X, Dong C, Liu P, Zhang F, Hu J, Qi Y, Zhang J, Li Q, Yan B. The Preclinical Research Progress of Stem Cells Therapy in Parkinson's Disease. Biomed Research International. 2016: 5683097. PMID 27379248 DOI: 10.1155/2016/5683097 |
0.344 |
|
| 2016 |
Kang W, Chen W, Yang Q, Zhang L, Zhang L, Wang X, Dong F, Zhao Y, Chen S, Quinn TJ, Zhang J, Chen S, Liu J. Salivary total α-synuclein, oligomeric α-synuclein and SNCA variants in Parkinson's disease patients. Scientific Reports. 6: 28143. PMID 27335051 DOI: 10.1038/srep28143 |
0.415 |
|
| 2016 |
Wang S, Chu CH, Guo M, Jiang L, Nie H, Zhang W, Wilson B, Yang L, Stewart T, Hong JS, Zhang J. Identification of a specific α-synuclein peptide (α-Syn 29-40) capable of eliciting microglial superoxide production to damage dopaminergic neurons. Journal of Neuroinflammation. 13: 158. PMID 27329107 DOI: 10.1186/S12974-016-0606-7 |
0.345 |
|
| 2016 |
Shi M, Kovac A, Korff A, Cook TJ, Ginghina C, Bullock KM, Yang L, Stewart T, Zheng D, Aro P, Atik A, Kerr KF, Zabetian CP, Peskind ER, Hu SC, ... ... Zhang J, et al. CNS tau efflux via exosomes is likely increased in Parkinson disease but not in Alzheimer disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 27234211 DOI: 10.1016/J.Jalz.2016.04.003 |
0.764 |
|
| 2016 |
Atik A, Stewart T, Zhang J. Alpha-synuclein as a biomarker for Parkinson's disease. Brain Pathology (Zurich, Switzerland). PMID 26940058 DOI: 10.1111/Bpa.12370 |
0.513 |
|
| 2016 |
Stern RA, Tripodis Y, Baugh CM, Fritts NG, Martin BM, Chaisson C, Cantu RC, Joyce JA, Shah S, Ikezu T, Zhang J, Gercel-Taylor C, Taylor DD. Preliminary Study of Plasma Exosomal Tau as a Potential Biomarker for Chronic Traumatic Encephalopathy. Journal of Alzheimer's Disease : Jad. PMID 26890775 DOI: 10.3233/Jad-151028 |
0.346 |
|
| 2016 |
Hossein-Nezhad A, Fatemi RP, Ahmad R, Peskind E, Zabeitian C, Hu SC, Shi M, Wahlestedt C, Zhang J, Faghihi MA. Transcriptomic Profiling of Extracellular RNAs Present in Cerebrospinal Fluid Identifies Differentially Expressed Transcripts in Parkinson's Diseases. Journal of Parkinson's Disease. PMID 26889637 DOI: 10.3233/Jpd-150737 |
0.43 |
|
| 2016 |
Tian T, Sun Y, Wu H, Pei J, Zhang J, Zhang Y, Wang L, Li B, Wang L, Shi J, Hu J, Fan C. Acupuncture promotes mTOR-independent autophagic clearance of aggregation-prone proteins in mouse brain. Scientific Reports. 6: 19714. PMID 26792101 DOI: 10.1038/Srep19714 |
0.387 |
|
| 2016 |
Huber BR, Meabon JS, Hoffer ZS, Zhang J, Hoekstra JG, Pagulayan KF, McMillan PJ, Mayer CL, Banks WA, Kraemer BC, Raskind MA, McGavern DB, Peskind ER, Cook DG. Blast Exposure Causes Dynamic Microglial/Macrophage Responses and Microdomains of Brain Microvessel Dysfunction. Neuroscience. PMID 26777891 DOI: 10.1016/J.Neuroscience.2016.01.022 |
0.749 |
|
| 2015 |
Rosenthal LS, Drake D, Alcalay RN, Babcock D, Bowman FD, Chen-Plotkin A, Dawson TM, Dewey RB, German DC, Huang X, Landin B, McAuliffe M, Petyuk VA, Scherzer CR, Hillaire-Clarke CS, ... ... Zhang J, et al. The NINDS Parkinson's disease biomarkers program. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 26442452 DOI: 10.1002/Mds.26438 |
0.467 |
|
| 2015 |
Li G, Xiong K, Korff A, Pan C, Quinn JF, Galasko DR, Liu C, Montine TJ, Peskind ER, Zhang J. Increased CSF E-Selectin in Clinical Alzheimer's Disease without Altered CSF Aβ42 and Tau. Journal of Alzheimer's Disease : Jad. 47: 883-7. PMID 26401768 DOI: 10.3233/Jad-150420 |
0.51 |
|
| 2015 |
Madhyastha TM, Askren MK, Zhang J, Leverenz JB, Montine TJ, Grabowski TJ. Group comparison of spatiotemporal dynamics of intrinsic networks in Parkinson's disease. Brain : a Journal of Neurology. 138: 2672-86. PMID 26173859 DOI: 10.1093/Brain/Awv189 |
0.503 |
|
| 2015 |
Cook TJ, Hoekstra JG, Eaton DL, Zhang J. Mortalin is expressed by astrocytes and decreased in the midbrain of Parkinson's disease patients. Brain Pathology (Zurich, Switzerland). PMID 26095919 DOI: 10.1111/Bpa.12274 |
0.827 |
|
| 2015 |
Yang Y, Keene CD, Peskind ER, Galasko DR, Hu SC, Cudaback E, Wilson AM, Li G, Yu CE, Montine KS, Zhang J, Baird GS, Hyman BT, Montine TJ. Cerebrospinal Fluid Particles in Alzheimer Disease and Parkinson Disease. Journal of Neuropathology and Experimental Neurology. 74: 672-87. PMID 26083568 DOI: 10.1097/Nen.0000000000000207 |
0.519 |
|
| 2015 |
Jiang T, Hoekstra J, Heng X, Kang W, Ding J, Liu J, Chen S, Zhang J. P2X7 receptor is critical in α-synuclein-mediated microglial NADPH oxidase activation. Neurobiology of Aging. 36: 2304-18. PMID 25983062 DOI: 10.1016/J.Neurobiolaging.2015.03.015 |
0.794 |
|
| 2015 |
Laurens B, Constantinescu R, Freeman R, Gerhard A, Jellinger K, Jeromin A, Krismer F, Mollenhauer B, Schlossmacher MG, Shaw LM, Verbeek MM, Wenning GK, Winge K, Zhang J, Meissner WG. Fluid biomarkers in multiple system atrophy: A review of the MSA Biomarker Initiative. Neurobiology of Disease. 80: 29-41. PMID 25982836 DOI: 10.1016/J.Nbd.2015.05.004 |
0.381 |
|
| 2015 |
Wang S, Chu CH, Stewart T, Ginghina C, Wang Y, Nie H, Guo M, Wilson B, Hong JS, Zhang J. α-Synuclein, a chemoattractant, directs microglial migration via H2O2-dependent Lyn phosphorylation. Proceedings of the National Academy of Sciences of the United States of America. 112: E1926-35. PMID 25825709 DOI: 10.1073/Pnas.1417883112 |
0.382 |
|
| 2015 |
Bekris LM, Tsuang DW, Peskind ER, Yu CE, Montine TJ, Zhang J, Zabetian CP, Leverenz JB. Cerebrospinal fluid Aβ42 levels and APP processing pathway genes in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 936-44. PMID 25808939 DOI: 10.1002/Mds.26172 |
0.613 |
|
| 2015 |
Madhyastha TM, Askren MK, Boord P, Zhang J, Leverenz JB, Grabowski TJ. Cerebral perfusion and cortical thickness indicate cortical involvement in mild Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 25759166 DOI: 10.1002/Mds.26128 |
0.385 |
|
| 2015 |
Srivatsal S, Cholerton B, Leverenz JB, Wszolek ZK, Uitti RJ, Dickson DW, Weintraub D, Trojanowski JQ, Van Deerlin VM, Quinn JF, Chung KA, Peterson AL, Factor SA, Wood-Siverio C, Goldman JG, ... ... Zhang J, et al. Cognitive profile of LRRK2-related Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 728-33. PMID 25650144 DOI: 10.1002/Mds.26161 |
0.583 |
|
| 2015 |
Stewart T, Sossi V, Aasly JO, Wszolek ZK, Uitti RJ, Hasegawa K, Yokoyama T, Zabetian CP, Leverenz JB, Stoessl AJ, Wang Y, Ginghina C, Liu C, Cain KC, Auinger P, ... ... Zhang J, et al. Phosphorylated α-synuclein in Parkinson's disease: correlation depends on disease severity. Acta Neuropathologica Communications. 3: 7. PMID 25637461 DOI: 10.1186/S40478-015-0185-3 |
0.502 |
|
| 2015 |
Lin X, Shi M, Masilamoni JG, Dator R, Movius J, Aro P, Smith Y, Zhang J. Proteomic profiling in MPTP monkey model for early Parkinson disease biomarker discovery. Biochimica Et Biophysica Acta. 1854: 779-87. PMID 25617661 DOI: 10.1016/j.bbapap.2015.01.007 |
0.484 |
|
| 2015 |
Pan C, Korff A, Galasko D, Ginghina C, Peskind E, Li G, Quinn J, Montine TJ, Cain K, Shi M, Zhang J. Diagnostic Values of Cerebrospinal Fluid T-Tau and Aβ₄₂ using Meso Scale Discovery Assays for Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. 45: 709-19. PMID 25613100 DOI: 10.3233/Jad-143099 |
0.525 |
|
| 2015 |
Liu C, Cholerton B, Shi M, Ginghina C, Cain KC, Auinger P, Zhang J. CSF tau and tau/Aβ42 predict cognitive decline in Parkinson's disease. Parkinsonism & Related Disorders. 21: 271-6. PMID 25596881 DOI: 10.1016/j.parkreldis.2014.12.027 |
0.457 |
|
| 2015 |
Shi M, Movius J, Dator R, Aro P, Zhao Y, Pan C, Lin X, Bammler TK, Stewart T, Zabetian CP, Peskind ER, Hu SC, Quinn JF, Galasko DR, Zhang J. Cerebrospinal fluid peptides as potential Parkinson disease biomarkers: a staged pipeline for discovery and validation. Molecular & Cellular Proteomics : McP. 14: 544-55. PMID 25556233 DOI: 10.1074/Mcp.M114.040576 |
0.473 |
|
| 2015 |
Hoekstra JG, Cook TJ, Stewart T, Mattison H, Dreisbach MT, Hoffer ZS, Zhang J. Astrocytic dynamin-like protein 1 regulates neuronal protection against excitotoxicity in Parkinson disease. The American Journal of Pathology. 185: 536-49. PMID 25482923 DOI: 10.1016/J.Ajpath.2014.10.022 |
0.802 |
|
| 2015 |
Searles Nielsen S, Checkoway H, Zhang J, Hofmann JN, Keifer MC, Paulsen M, Farin FM, Cook TJ, Simpson CD. Blood α-synuclein in agricultural pesticide handlers in central Washington State. Environmental Research. 136: 75-81. PMID 25460623 DOI: 10.1016/J.Envres.2014.10.014 |
0.649 |
|
| 2015 |
Cao C, Li D, Jiang T, Ince NF, Zhan S, Zhang J, Sha Z, Sun B. Resting state cortical oscillations of patients with Parkinson disease and with and without subthalamic deep brain stimulation: a magnetoencephalography study. Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society. 32: 109-18. PMID 25233246 DOI: 10.1097/WNP.0000000000000137 |
0.311 |
|
| 2015 |
Mackin RS, Insel P, Zhang J, Mohlenhoff B, Galasko D, Weiner M, Mattsson N. Cerebrospinal fluid α-synuclein and Lewy body-like symptoms in normal controls, mild cognitive impairment, and Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 43: 1007-16. PMID 25125463 DOI: 10.3233/Jad-141287 |
0.404 |
|
| 2014 |
Toledo JB, Korff A, Shaw LM, Trojanowski JQ, Zhang J. Low levels of cerebrospinal fluid complement 3 and factor H predict faster cognitive decline in mild cognitive impairment. Alzheimer's Research & Therapy. 6: 36. PMID 25478014 DOI: 10.1186/Alzrt266 |
0.357 |
|
| 2014 |
Ou J, Xie L, Li X, Zhu D, Terry DP, Puente AN, Jiang R, Chen Y, Wang L, Shen D, Zhang J, Miller LS, Liu T. Atomic connectomics signatures for characterization and differentiation of mild cognitive impairment. Brain Imaging and Behavior. PMID 25355371 DOI: 10.1007/S11682-014-9320-1 |
0.545 |
|
| 2014 |
Sui YT, Bullock KM, Erickson MA, Zhang J, Banks WA. Alpha synuclein is transported into and out of the brain by the blood-brain barrier. Peptides. 62: 197-202. PMID 25278492 DOI: 10.1016/j.peptides.2014.09.018 |
0.412 |
|
| 2014 |
Shi M, Liu C, Cook TJ, Bullock KM, Zhao Y, Ginghina C, Li Y, Aro P, Dator R, He C, Hipp MJ, Zabetian CP, Peskind ER, Hu SC, Quinn JF, ... ... Zhang J, et al. Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson's disease. Acta Neuropathologica. 128: 639-50. PMID 24997849 DOI: 10.1007/S00401-014-1314-Y |
0.698 |
|
| 2014 |
Pan C, Zhou Y, Dator R, Ginghina C, Zhao Y, Movius J, Peskind E, Zabetian CP, Quinn J, Galasko D, Stewart T, Shi M, Zhang J. Targeted discovery and validation of plasma biomarkers of Parkinson's disease. Journal of Proteome Research. 13: 4535-45. PMID 24853996 DOI: 10.1021/Pr500421V |
0.48 |
|
| 2014 |
Li G, Millard SP, Peskind ER, Zhang J, Yu CE, Leverenz JB, Mayer C, Shofer JS, Raskind MA, Quinn JF, Galasko DR, Montine TJ. Cross-sectional and longitudinal relationships between cerebrospinal fluid biomarkers and cognitive function in people without cognitive impairment from across the adult life span. Jama Neurology. 71: 742-51. PMID 24756381 DOI: 10.1001/Jamaneurol.2014.445 |
0.478 |
|
| 2014 |
Devic I, Shi M, Schubert MM, Lloid M, Izutsu KT, Pan C, Missaghi M, Morton TH, Mancl LA, Zhang J, Presland RB. Proteomic analysis of saliva from patients with oral chronic graft-versus-host disease. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 20: 1048-55. PMID 24704387 DOI: 10.1016/J.Bbmt.2014.03.031 |
0.309 |
|
| 2014 |
Stewart T, Liu C, Ginghina C, Cain KC, Auinger P, Cholerton B, Shi M, Zhang J. Cerebrospinal fluid α-synuclein predicts cognitive decline in Parkinson disease progression in the DATATOP cohort. The American Journal of Pathology. 184: 966-75. PMID 24625392 DOI: 10.1016/J.Ajpath.2013.12.007 |
0.409 |
|
| 2014 |
Stewart T, Sui YT, Gonzalez-Cuyar LF, Wong DT, Akin DM, Tumas V, Aasly J, Ashmore E, Aro P, Ginghina C, Korff A, Zabetian CP, Leverenz JB, Shi M, Zhang J. Cheek cell-derived α-synuclein and DJ-1 do not differentiate Parkinson's disease from control. Neurobiology of Aging. 35: 418-20. PMID 24041968 DOI: 10.1016/J.Neurobiolaging.2013.08.008 |
0.461 |
|
| 2014 |
Peskind ER, Petrie EC, Pagulayan KF, Yarnykh V, Cross DJ, Richards T, Raskind MA, Zhang J, Montine T, Minoshima S. Persistent Brain Neuroimaging And Neurocognitive Abnormalities In Military Veterans Who Experienced Blast Mild Traumatic Brain Injury In Iraq And Afghanistan Alzheimers & Dementia. 10: 294. DOI: 10.1016/J.Jalz.2014.04.487 |
0.436 |
|
| 2013 |
Mattsson N, Insel P, Tosun D, Zhang J, Jack CR, Galasko D, Weiner M. Effects of baseline CSF α-synuclein on regional brain atrophy rates in healthy elders, mild cognitive impairment and Alzheimer's disease. Plos One. 8: e85443. PMID 24392009 DOI: 10.1371/Journal.Pone.0085443 |
0.387 |
|
| 2013 |
Chen H, Burton EA, Ross GW, Huang X, Savica R, Abbott RD, Ascherio A, Caviness JN, Gao X, Gray KA, Hong JS, Kamel F, Jennings D, Kirshner A, Lawler C, ... ... Zhang J, et al. Research on the premotor symptoms of Parkinson's disease: clinical and etiological implications. Environmental Health Perspectives. 121: 1245-52. PMID 23933572 DOI: 10.1289/Ehp.1306967 |
0.59 |
|
| 2013 |
Toledo JB, Korff A, Shaw LM, Trojanowski JQ, Zhang J. CSF α-synuclein improves diagnostic and prognostic performance of CSF tau and Aβ in Alzheimer's disease. Acta Neuropathologica. 126: 683-97. PMID 23812319 DOI: 10.1007/S00401-013-1148-Z |
0.436 |
|
| 2013 |
Hanson AJ, Bayer-Carter JL, Green PS, Montine TJ, Wilkinson CW, Baker LD, Watson GS, Bonner LM, Callaghan M, Leverenz JB, Tsai E, Postupna N, Zhang J, Lampe J, Craft S. Effect of apolipoprotein E genotype and diet on apolipoprotein E lipidation and amyloid peptides: randomized clinical trial. Jama Neurology. 70: 972-80. PMID 23779114 DOI: 10.1001/Jamaneurol.2013.396 |
0.367 |
|
| 2013 |
Li D, Cao C, Zhang J, Zhan S, Chen S, Sun B. Subthalamic nucleus deep brain stimulation for Parkinson's disease: 8 years of follow-up. Translational Neurodegeneration. 2: 11. PMID 23706134 DOI: 10.1186/2047-9158-2-11 |
0.31 |
|
| 2013 |
Zhang J, Mattison HA, Liu C, Ginghina C, Auinger P, McDermott MP, Stewart T, Kang UJ, Cain KC, Shi M. Longitudinal assessment of tau and amyloid beta in cerebrospinal fluid of Parkinson disease. Acta Neuropathologica. 126: 671-82. PMID 23644819 DOI: 10.1007/S00401-013-1121-X |
0.452 |
|
| 2013 |
Korff A, Liu C, Ginghina C, Shi M, Zhang J. α-Synuclein in cerebrospinal fluid of Alzheimer's disease and mild cognitive impairment. Journal of Alzheimer's Disease : Jad. 36: 679-88. PMID 23603399 DOI: 10.3233/JAD-130458 |
0.42 |
|
| 2013 |
Shi M, Hwang H, Zhang J. Quantitative characterization of glycoproteins in neurodegenerative disorders using iTRAQ. Methods of Molecular Biology. 951: 279-296. PMID 23296538 DOI: 10.1007/978-1-62703-146-2_19 |
0.397 |
|
| 2013 |
Lock EA, Zhang J, Checkoway H. Solvents and Parkinson disease: A systematic review of toxicological and epidemiological evidence Toxicology and Applied Pharmacology. 266: 345-355. PMID 23220449 DOI: 10.1016/J.Taap.2012.11.016 |
0.432 |
|
| 2013 |
Wang J, Hoekstra JG, Zuo C, Cook TJ, Zhang J. Biomarkers of Parkinson's disease: current status and future perspectives. Drug Discovery Today. 18: 155-62. PMID 22982303 DOI: 10.1016/J.Drudis.2012.09.001 |
0.813 |
|
| 2013 |
Peskind E, Petrie E, Cross D, Li G, Mayer C, Minoshima S, Zhang J, Montine T, Raskind M. Cerebrospinal fluid biomarkers and PET imaging of cerebral glucose metabolism in Iraq and Afghanistan veterans: Converging evidence of brain dysfunction and neurodegeneration Alzheimers & Dementia. 9: 229. DOI: 10.1016/J.Jalz.2013.05.434 |
0.454 |
|
| 2012 |
Lin X, Cook TJ, Zabetian CP, Leverenz JB, Peskind ER, Hu SC, Cain KC, Pan C, Edgar JS, Goodlett DR, Racette BA, Checkoway H, Montine TJ, Shi M, Zhang J. DJ-1 isoforms in whole blood as potential biomarkers of Parkinson disease. Scientific Reports. 2: 954. PMID 23233873 DOI: 10.1038/Srep00954 |
0.761 |
|
| 2012 |
Haas BR, Stewart TH, Zhang J. Premotor biomarkers for Parkinson's disease - a promising direction of research. Translational Neurodegeneration. 1: 11. PMID 23211054 DOI: 10.1186/2047-9158-1-11 |
0.475 |
|
| 2012 |
Mattison HA, Stewart T, Zhang J. Applying bioinformatics to proteomics: is machine learning the answer to biomarker discovery for PD and MSA? Movement Disorders : Official Journal of the Movement Disorder Society. 27: 1595-7. PMID 23115026 DOI: 10.1002/Mds.25189 |
0.416 |
|
| 2012 |
Racette BA, Criswell SR, Lundin JI, Hobson A, Seixas N, Kotzbauer PT, Evanoff BA, Perlmutter JS, Zhang J, Sheppard L, Checkoway H. Increased risk of parkinsonism associated with welding exposure. Neurotoxicology. 33: 1356-61. PMID 22975422 DOI: 10.1016/J.Neuro.2012.08.011 |
0.421 |
|
| 2012 |
Mollenhauer B, Zhang J. Biochemical premotor biomarkers for Parkinson's disease Movement Disorders. 27: 644-650. PMID 22508282 DOI: 10.1002/mds.24956 |
0.43 |
|
| 2012 |
Wang Y, Shi M, Chung KA, Zabetian CP, Leverenz JB, Berg D, Srulijes K, Trojanowski JQ, Lee VM, Siderowf AD, Hurtig H, Litvan I, Schiess MC, Peskind ER, Masuda M, ... ... Zhang J, et al. Phosphorylated α-synuclein in Parkinson's disease. Science Translational Medicine. 4: 121ra20. PMID 22344688 DOI: 10.1126/Scitranslmed.3002566 |
0.483 |
|
| 2012 |
Zhang ZG, Wu L, Wang JL, Yang JD, Zhang J, Zhang J, Li LH, Xia Y, Yao LB, Qin HZ, Gao GD. Astragaloside IV prevents MPP⁺-induced SH-SY5Y cell death via the inhibition of Bax-mediated pathways and ROS production. Molecular and Cellular Biochemistry. 364: 209-16. PMID 22278385 DOI: 10.1007/s11010-011-1219-1 |
0.33 |
|
| 2012 |
Aasly JO, Shi M, Sossi V, Stewart T, Johansen KK, Wszolek ZK, Uitti RJ, Hasegawa K, Yokoyama T, Zabetian CP, Kim HM, Leverenz JB, Ginghina C, Armaly J, Edwards KL, ... ... Zhang J, et al. Cerebrospinal fluid amyloid β and tau in LRRK2 mutation carriers. Neurology. 78: 55-61. PMID 22170881 DOI: 10.1212/Wnl.0B013E31823Ed101 |
0.472 |
|
| 2012 |
Shi M, Furay AR, Sossi V, Aasly JO, Armaly J, Wang Y, Wszolek ZK, Uitti RJ, Hasegawa K, Yokoyama T, Zabetian CP, Leverenz JB, Stoessl AJ, Zhang J. DJ-1 and αSYN in LRRK2 CSF do not correlate with striatal dopaminergic function. Neurobiology of Aging. 33: 836.e5-7. PMID 22019052 DOI: 10.1016/J.Neurobiolaging.2011.09.015 |
0.453 |
|
| 2012 |
Pan C, Lu S, Shi M, Zhang J. 2.145 Identification Of Plasma Glycoproteins As Biomarkers Of Patients With Parkinson'S Disease Parkinsonism & Related Disorders. 18. DOI: 10.1016/S1353-8020(11)70517-X |
0.408 |
|
| 2012 |
Maccecchini M, Zhang J, Zetterberg H. Microglia activation in the Alzheimer's brain: Normalization by Posiphen® Alzheimers & Dementia. 8: 267. DOI: 10.1016/J.Jalz.2012.05.714 |
0.335 |
|
| 2011 |
Shi M, Sui YT, Peskind ER, Li G, Hwang H, Devic I, Ginghina C, Edgar JS, Pan C, Goodlett DR, Furay AR, Gonzalez-Cuyar LF, Zhang J. Salivary tau species are potential biomarkers of Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 27: 299-305. PMID 21841250 DOI: 10.3233/Jad-2011-110731 |
0.383 |
|
| 2011 |
Mattsson N, Andreasson U, Persson S, Arai H, Batish SD, Bernardini S, Bocchio-Chiavetto L, Blankenstein MA, Carrillo MC, Chalbot S, Coart E, Chiasserini D, Cutler N, Dahlfors G, Duller S, ... ... Zhang J, et al. The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 7: 386-395.e6. PMID 21784349 DOI: 10.1016/J.Jalz.2011.05.2243 |
0.498 |
|
| 2011 |
Shi M, Zhang J. CSF α-synuclein, tau, and amyloid β in Parkinson's disease The Lancet Neurology. 10: 681. PMID 21777821 DOI: 10.1016/S1474-4422(11)70130-2 |
0.418 |
|
| 2011 |
Hoekstra JG, Montine KS, Zhang J, Montine TJ. Mitochondrial therapeutics in Alzheimer's disease and Parkinson's disease. Alzheimer's Research & Therapy. 3: 21. PMID 21722346 DOI: 10.1186/Alzrt83 |
0.801 |
|
| 2011 |
Bayer-Carter JL, Green PS, Montine TJ, VanFossen B, Baker LD, Watson GS, Bonner LM, Callaghan M, Leverenz JB, Walter BK, Tsai E, Plymate SR, Postupna N, Wilkinson CW, Zhang J, et al. Diet intervention and cerebrospinal fluid biomarkers in amnestic mild cognitive impairment. Archives of Neurology. 68: 743-52. PMID 21670398 DOI: 10.1001/Archneurol.2011.125 |
0.435 |
|
| 2011 |
Wang Y, Hancock AM, Bradner J, Chung KA, Quinn JF, Peskind ER, Galasko D, Jankovic J, Zabetian CP, Kim HM, Leverenz JB, Montine TJ, Ginghina C, Edwards KL, Snapinn KW, ... ... Zhang J, et al. Complement 3 and factor h in human cerebrospinal fluid in Parkinson's disease, Alzheimer's disease, and multiple-system atrophy. The American Journal of Pathology. 178: 1509-16. PMID 21435440 DOI: 10.1016/J.Ajpath.2011.01.006 |
0.795 |
|
| 2011 |
Shi M, Bradner J, Hancock AM, Chung KA, Quinn JF, Peskind ER, Galasko D, Jankovic J, Zabetian CP, Kim HM, Leverenz JB, Montine TJ, Ginghina C, Kang UJ, Cain KC, ... ... Zhang J, et al. Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression. Annals of Neurology. 69: 570-80. PMID 21400565 DOI: 10.1002/Ana.22311 |
0.802 |
|
| 2011 |
Devic I, Hwang H, Edgar JS, Izutsu K, Presland R, Pan C, Goodlett DR, Wang Y, Armaly J, Tumas V, Zabetian CP, Leverenz JB, Shi M, Zhang J. Salivary α-synuclein and DJ-1: potential biomarkers for Parkinson's disease. Brain : a Journal of Neurology. 134: e178. PMID 21349902 DOI: 10.1093/Brain/Awr015 |
0.479 |
|
| 2011 |
Leverenz JB, Watson GS, Shofer J, Zabetian CP, Zhang J, Montine TJ. Cerebrospinal fluid biomarkers and cognitive performance in non-demented patients with Parkinson's disease. Parkinsonism & Related Disorders. 17: 61-4. PMID 21044858 DOI: 10.1016/J.Parkreldis.2010.10.003 |
0.571 |
|
| 2010 |
Mata IF, Shi M, Agarwal P, Chung KA, Edwards KL, Factor SA, Galasko DR, Ginghina C, Griffith A, Higgins DS, Kay DM, Kim H, Leverenz JB, Quinn JF, Roberts JW, ... ... Zhang J, et al. SNCA variant associated with Parkinson disease and plasma alpha-synuclein level. Archives of Neurology. 67: 1350-6. PMID 21060011 DOI: 10.1001/Archneurol.2010.279 |
0.384 |
|
| 2010 |
Montine TJ, Shi M, Quinn JF, Peskind ER, Craft S, Ginghina C, Chung KA, Kim H, Galasko DR, Jankovic J, Zabetian CP, Leverenz JB, Zhang J. CSF Aβ(42) and tau in Parkinson's disease with cognitive impairment. Movement Disorders : Official Journal of the Movement Disorder Society. 25: 2682-5. PMID 20818673 DOI: 10.1002/Mds.23287 |
0.597 |
|
| 2010 |
Shi M, Zabetian CP, Hancock AM, Ginghina C, Hong Z, Yearout D, Chung KA, Quinn JF, Peskind ER, Galasko D, Jankovic J, Leverenz JB, Zhang J. Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson's disease. Neuroscience Letters. 480: 78-82. PMID 20540987 DOI: 10.1016/J.Neulet.2010.06.009 |
0.723 |
|
| 2010 |
Shi M, Huber BR, Zhang J. Biomarkers for cognitive impairment in Parkinson disease. Brain Pathology (Zurich, Switzerland). 20: 660-71. PMID 20522092 DOI: 10.1111/j.1750-3639.2009.00370.x |
0.495 |
|
| 2010 |
Caudle WM, Bammler TK, Lin Y, Pan S, Zhang J. Using 'omics' to define pathogenesis and biomarkers of Parkinson's disease. Expert Review of Neurotherapeutics. 10: 925-42. PMID 20518609 DOI: 10.1586/Ern.10.54 |
0.733 |
|
| 2010 |
Liu J, Shi M, Hong Z, Zhang J, Bradner J, Quinn T, Beyer RP, Mcgeer PL, Chen S, Zhang J. Identification of ciliary neurotrophic factor receptor alpha as a mediator of neurotoxicity induced by alpha-synuclein. Proteomics. 10: 2138-50. PMID 20340160 DOI: 10.1002/Pmic.200900745 |
0.331 |
|
| 2010 |
Rostomily RC, Born DE, Beyer RP, Jin J, Alvord EC, Mikheev AM, Matthews RT, Pan C, Khorasani L, Sonnen JA, Montine TJ, Shi M, Zhang J. Quantitative proteomic analysis of oligodendrogliomas with and without 1p/19q deletion. Journal of Proteome Research. 9: 2610-8. PMID 20337498 DOI: 10.1021/Pr100054V |
0.438 |
|
| 2010 |
Hong Z, Shi M, Chung KA, Quinn JF, Peskind ER, Galasko D, Jankovic J, Zabetian CP, Leverenz JB, Baird G, Montine TJ, Hancock AM, Hwang H, Pan C, Bradner J, ... ... Zhang J, et al. DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease. Brain : a Journal of Neurology. 133: 713-26. PMID 20157014 DOI: 10.1093/Brain/Awq008 |
0.768 |
|
| 2010 |
Hwang H, Zhang J, Chung KA, Leverenz JB, Zabetian CP, Peskind ER, Jankovic J, Su Z, Hancock AM, Pan C, Montine TJ, Pan S, Nutt J, Albin R, Gearing M, ... ... Zhang J, et al. Glycoproteomics in neurodegenerative diseases. Mass Spectrometry Reviews. 29: 79-125. PMID 19358229 DOI: 10.1002/Mas.20221 |
0.789 |
|
| 2010 |
Craft S, Baker LD, Montine TJ, Zhang J, Watson GS, Plymate S, Tsai E, Callaghan M, Leverenz J, Gerton B, Trittschuh E. O4-08-01: Intranasal Insulin- And Biomarker-associated Improvement in Memory and Functional Status in Mild Cognitive Impairment and Alzheimer's Disease: Results of a Randomized, Double-blind, Placebo-controlled Pilot Trial Alzheimer's & Dementia. 6: e18-e18. DOI: 10.1016/J.Jalz.2010.08.054 |
0.469 |
|
| 2009 |
Hwang HJ, Quinn T, Zhang J. Identification of glycoproteins in human cerebrospinal fluid Methods in Molecular Biology. 566: 263-276. PMID 20058177 DOI: 10.1007/978-1-59745-562-6_17 |
0.397 |
|
| 2009 |
Caudle WM, Zhang J. Glutamate, excitotoxicity, and programmed cell death in Parkinson disease. Experimental Neurology. 220: 230-3. PMID 19815009 DOI: 10.1016/j.expneurol.2009.09.027 |
0.663 |
|
| 2009 |
Leverenz JB, Quinn JF, Zabetian C, Zhang J, Montine KS, Montine TJ. Cognitive impairment and dementia in patients with Parkinson disease. Current Topics in Medicinal Chemistry. 9: 903-12. PMID 19754405 DOI: 10.2174/156802609789378218 |
0.594 |
|
| 2009 |
Shi M, Bradner J, Bammler TK, Eaton DL, Zhang J, Ye Z, Wilson AM, Montine TJ, Pan C, Zhang J. Identification of glutathione S-transferase pi as a protein involved in Parkinson disease progression. The American Journal of Pathology. 175: 54-65. PMID 19498008 DOI: 10.2353/Ajpath.2009.081019 |
0.618 |
|
| 2009 |
Caudle WM, Kitsou E, Li J, Bradner J, Zhang J. A role for a novel protein, nucleolin, in Parkinson's disease. Neuroscience Letters. 459: 11-5. PMID 19409963 DOI: 10.1016/j.neulet.2009.04.060 |
0.735 |
|
| 2009 |
Liu J, Zhang JP, Shi M, Quinn T, Bradner J, Beyer R, Chen S, Zhang J. Rab11a and HSP90 regulate recycling of extracellular α-synuclein Journal of Neuroscience. 29: 1480-1485. PMID 19193894 DOI: 10.1523/Jneurosci.6202-08.2009 |
0.426 |
|
| 2009 |
Shi M, Caudle WM, Zhang J. Biomarker discovery in neurodegenerative diseases: a proteomic approach. Neurobiology of Disease. 35: 157-64. PMID 18938247 DOI: 10.1016/j.nbd.2008.09.004 |
0.725 |
|
| 2009 |
Costa-Mallen P, Zabetian C, Zhang J, Samii A, Grifflth A, Roberts J, Checkoway H. P3.103 Serum iron levels are lower in Parkinson's disease patients as compared to controls and are modifled by haptoglobin phenotype Parkinsonism & Related Disorders. 15: S174. DOI: 10.1016/S1353-8020(09)70667-4 |
0.343 |
|
| 2008 |
Kitsou E, Pan S, Zhang J, Shi M, Zabeti A, Dickson DW, Albin R, Gearing M, Kashima DT, Wang Y, Beyer RP, Zhou Y, Pan C, Caudle WM, Zhang J. Identification of proteins in human substantia nigra. Proteomics. Clinical Applications. 2: 776-82. PMID 21136874 DOI: 10.1002/Prca.200800028 |
0.722 |
|
| 2008 |
Caudle WM, Pan S, Shi M, Quinn T, Hoekstra J, Beyer RP, Montine TJ, Zhang J. Proteomic identification of proteins in the human brain: Towards a more comprehensive understanding of neurodegenerative disease. Proteomics. Clinical Applications. 2: 1484-97. PMID 21136796 DOI: 10.1002/Prca.200800043 |
0.804 |
|
| 2008 |
Hu X, Zhang D, Pang H, Caudle WM, Li Y, Gao H, Liu Y, Qian L, Wilson B, Di Monte DA, Ali SF, Zhang J, Block ML, Hong JS. Macrophage antigen complex-1 mediates reactive microgliosis and progressive dopaminergic neurodegeneration in the MPTP model of Parkinson's disease. Journal of Immunology (Baltimore, Md. : 1950). 181: 7194-204. PMID 18981141 DOI: 10.4049/Jimmunol.181.10.7194 |
0.683 |
|
| 2008 |
Zhang J, Keene CD, Pan C, Montine KS, Montine TJ. Proteomics of human neurodegenerative diseases. Journal of Neuropathology and Experimental Neurology. 67: 923-32. PMID 18800015 DOI: 10.1097/Nen.0B013E318187A832 |
0.558 |
|
| 2008 |
Liu J, Hong Z, Ding J, Zhang J, Chen S. Predominant release of lysosomal enzymes by newborn rat microglia after LPS treatment revealed by proteomic studies Journal of Proteome Research. 7: 2033-2049. PMID 18380473 DOI: 10.1021/pr7007779 |
0.355 |
|
| 2008 |
Zhang J, Sokal I, Peskind ER, Quinn JF, Jankovic J, Kenney C, Chung KA, Millard SP, Nutt JG, Montine TJ. CSF multianalyte profile distinguishes Alzheimer and Parkinson diseases. American Journal of Clinical Pathology. 129: 526-9. PMID 18343778 DOI: 10.1309/W01Y0B808Emeh12L |
0.604 |
|
| 2008 |
Klegeris A, Li J, Bammler TK, Jin J, Zhu D, Kashima DT, Pan S, Hashioka S, Maguire J, McGeer PL, Zhang J. Prolyl endopeptidase is revealed following SILAC analysis to be a novel mediator of human microglial and THP-1 cell neurotoxicity. Glia. 56: 675-85. PMID 18293395 DOI: 10.1002/Glia.20645 |
0.319 |
|
| 2008 |
Shi M, Jin J, Wang Y, Beyer RP, Kitsou E, Albin RL, Gearing M, Pan C, Zhang J. Mortalin: a protein associated with progression of Parkinson disease? Journal of Neuropathology and Experimental Neurology. 67: 117-24. PMID 18219256 DOI: 10.1097/Nen.0B013E318163354A |
0.49 |
|
| 2008 |
Pan S, Rush J, Peskind ER, Galasko D, Chung K, Quinn J, Jankovic J, Leverenz JB, Zabetian C, Pan C, Wang Y, Jung HO, Gao J, Zhang J, Montine T. Application of targeted quantitative proteomics analysis in human cerebrospinal fluid using a liquid chromatography matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometer (LC MALDI TOF/TOF) platform Journal of Proteome Research. 7: 720-730. PMID 18186601 DOI: 10.1021/Pr700630X |
0.503 |
|
| 2007 |
Zhang J. Proteomics of human cerebrospinal fluid - the good, the bad, and the ugly. Proteomics. Clinical Applications. 1: 805-19. PMID 21136735 DOI: 10.1002/prca.200700081 |
0.312 |
|
| 2007 |
Zhang J. Proteomics of human cerebrospinal fluid - the good, the bad, and the ugly. Proteomics. Clinical Applications. 1: 805-19. PMID 21136735 DOI: 10.1002/prca.200700081 |
0.312 |
|
| 2007 |
Jin J, Davis J, Zhu D, Kashima DT, Leroueil M, Pan C, Montine KS, Zhang J. Identification of novel proteins affected by rotenone in mitochondria of dopaminergic cells. Bmc Neuroscience. 8: 67. PMID 17705834 DOI: 10.1186/1471-2202-8-67 |
0.405 |
|
| 2007 |
Li G, Sokal I, Quinn JF, Leverenz JB, Brodey M, Schellenberg GD, Kaye JA, Raskind MA, Zhang J, Peskind ER, Montine TJ. CSF tau/Abeta42 ratio for increased risk of mild cognitive impairment: a follow-up study. Neurology. 69: 631-9. PMID 17698783 DOI: 10.1212/01.wnl.0000267428.62582.aa |
0.499 |
|
| 2007 |
Sonnen JA, Keene CD, Montine KS, Li G, Peskind ER, Zhang J, Montine TJ. Biomarkers for Alzheimer's disease. Expert Review of Neurotherapeutics. 7: 1021-8. PMID 17678497 DOI: 10.3233/Jad-2005-8401 |
0.457 |
|
| 2007 |
Yang W, Woltjer RL, Sokal I, Pan C, Wang Y, Brodey M, Peskind ER, Leverenz JB, Zhang J, Perl DP, Galasko DR, Montine TJ. Quantitative proteomics identifies surfactant-resistant alpha-synuclein in cerebral cortex of Parkinsonism-dementia complex of Guam but not Alzheimer's disease or progressive supranuclear palsy. The American Journal of Pathology. 171: 993-1002. PMID 17675576 DOI: 10.2353/Ajpath.2007.070015 |
0.539 |
|
| 2007 |
Pan S, Shi M, Jin J, Albin RL, Lieberman A, Gearing M, Lin B, Pan C, Yan X, Kashima DT, Zhang J. Proteomics identification of proteins in human cortex using multidimensional separations and MALDI tandem mass spectrometer. Molecular & Cellular Proteomics : McP. 6: 1818-23. PMID 17644759 DOI: 10.1074/Mcp.M700158-Mcp200 |
0.368 |
|
| 2007 |
Leverenz JB, Umar I, Wang Q, Montine TJ, McMillan PJ, Tsuang DW, Jin J, Pan C, Shin J, Zhu D, Zhang J. Proteomic identification of novel proteins in cortical lewy bodies. Brain Pathology (Zurich, Switzerland). 17: 139-45. PMID 17388944 DOI: 10.1111/J.1750-3639.2007.00048.X |
0.568 |
|
| 2007 |
Chen L, Jin J, Davis J, Zhou Y, Wang Y, Liu J, Lockhart PJ, Zhang J. Oligomeric α-synuclein inhibits tubulin polymerization Biochemical and Biophysical Research Communications. 356: 548-553. PMID 17374364 DOI: 10.1016/j.bbrc.2007.02.163 |
0.305 |
|
| 2007 |
Zhang J, Montine TJ. Proteomic discovery of CSF biomarkers for Alzheimer's disease. Annals of Neurology. 61: 497; author reply 49. PMID 17358005 DOI: 10.1002/Ana.21109 |
0.57 |
|
| 2007 |
Pan S, Zhu D, Quinn JF, Peskind ER, Montine TJ, Lin B, Goodlett DR, Taylor G, Eng J, Zhang J. A combined dataset of human cerebrospinal fluid proteins identified by multi-dimensional chromatography and tandem mass spectrometry. Proteomics. 7: 469-73. PMID 17211832 DOI: 10.1002/Pmic.200600756 |
0.512 |
|
| 2007 |
Jin J, Shie FS, Liu J, Wang Y, Davis J, Schantz AM, Montine KS, Montine TJ, Zhang J. Prostaglandin E2 receptor subtype 2 (EP2) regulates microglial activation and associated neurotoxicity induced by aggregated alpha-synuclein. Journal of Neuroinflammation. 4: 2. PMID 17204153 DOI: 10.1186/1742-2094-4-2 |
0.527 |
|
| 2007 |
Jin J, Li GJ, Davis J, Zhu D, Wang Y, Pan C, Zhang J. Identification of novel proteins associated with both α-synuclein and DJ-1 Molecular and Cellular Proteomics. 6: 845-859. PMID 16854843 DOI: 10.1074/mcp.M600182-MCP200 |
0.36 |
|
| 2006 |
Pan S, Wang Y, Quinn JF, Peskind ER, Waichunas D, Wimberger JT, Jin J, Li JG, Zhu D, Pan C, Zhang J. Identification of glycoproteins in human cerebrospinal fluid with a complementary proteomic approach Journal of Proteome Research. 5: 2769-2779. PMID 17022648 DOI: 10.1021/pr060251s |
0.392 |
|
| 2006 |
Abdi F, Quinn JF, Jankovic J, McIntosh M, Leverenz JB, Peskind E, Nixon R, Nutt J, Chung K, Zabetian C, Samii A, Lin M, Hattan S, Pan C, Wang Y, ... ... Zhang J, et al. Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders. Journal of Alzheimer's Disease : Jad. 9: 293-348. PMID 16914840 DOI: 10.3233/Jad-2006-9309 |
0.616 |
|
| 2006 |
Montine TJ, Woltjer RL, Pan C, Montine KS, Zhang J. Liquid chromatography with tandem mass spectrometry-based proteomic discovery in aging and Alzheimer's disease. Neurorx : the Journal of the American Society For Experimental Neurotherapeutics. 3: 336-43. PMID 16815217 DOI: 10.1016/J.Nurx.2006.05.002 |
0.557 |
|
| 2006 |
Xu J, Chen J, Peskind ER, Jin J, Eng J, Pan C, Montine TJ, Goodlett DR, Zhang J. Characterization of proteome of human cerebrospinal fluid. International Review of Neurobiology. 73: 29-98. PMID 16737901 DOI: 10.1016/S0074-7742(06)73002-1 |
0.551 |
|
| 2006 |
Jin J, Hulette C, Wang Y, Zhang T, Pan C, Wadhwa R, Zhang J. Proteomic identification of a stress protein, mortalin/mthsp70/GRP75: relevance to Parkinson disease. Molecular & Cellular Proteomics : McP. 5: 1193-204. PMID 16565515 DOI: 10.1074/Mcp.M500382-Mcp200 |
0.474 |
|
| 2006 |
McLaughlin P, Zhou Y, Ma T, Liu J, Zhang W, Hong JS, Kovacs M, Zhang J. Proteomic analysis of microglial contribution to mouse strain-dependent dopaminergic neurotoxicity. Glia. 53: 567-82. PMID 16419087 DOI: 10.1002/Glia.20294 |
0.416 |
|
| 2006 |
J. Montine T, Quinn J, Peskind E, Pan C, Zhang J. O3-01-03: Multiplex quantitative proteomics of human cerebral spinal fluid from patients with neurodegenerative diseases Alzheimer's & Dementia. 2: S52-S52. DOI: 10.1016/J.Jalz.2006.05.189 |
0.48 |
|
| 2005 |
Zhang J, Goodlett DR, Montine TJ. Proteomic biomarker discovery in cerebrospinal fluid for neurodegenerative diseases. Journal of Alzheimer's Disease : Jad. 8: 377-86. PMID 16556969 DOI: 10.3233/Jad-2005-8407 |
0.6 |
|
| 2005 |
Woltjer RL, Cimino PJ, Boutté AM, Schantz AM, Montine KS, Larson EB, Bird T, Quinn JF, Zhang J, Montine TJ. Proteomic determination of widespread detergent-insolubility including Abeta but not tau early in the pathogenesis of Alzheimer's disease. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 19: 1923-5. PMID 16129700 DOI: 10.1096/Fj.05-4263Fje |
0.682 |
|
| 2005 |
Zhou Y, Wang Y, Kovacs M, Jin J, Zhang J. Microglial activation induced by neurodegeneration: A proteomic analysis Molecular and Cellular Proteomics. 4: 1471-1479. PMID 15975914 DOI: 10.1074/mcp.M500114-MCP200 |
0.371 |
|
| 2005 |
Zhang J, Goodlett DR, Quinn JF, Peskind E, Kaye JA, Zhou Y, Pan C, Yi E, Eng J, Wang Q, Aebersold RH, Montine TJ. Quantitative proteomics of cerebrospinal fluid from patients with Alzheimer disease. Journal of Alzheimer's Disease : Jad. 7: 125-33; discussion 1. PMID 15851850 DOI: 10.3233/Jad-2005-7205 |
0.535 |
|
| 2005 |
Zhang W, Wang T, Pei Z, Miller DS, Wu X, Block ML, Wilson B, Zhang W, Zhou Y, Hong JS, Zhang J. Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 19: 533-42. PMID 15791003 DOI: 10.1096/Fj.04-2751Com |
0.415 |
|
| 2005 |
Jin J, Meredith GE, Chen L, Zhou Y, Xu J, Shie FS, Lockhart P, Zhang J. Quantitative proteomic analysis of mitochondrial proteins: relevance to Lewy body formation and Parkinson's disease. Brain Research. Molecular Brain Research. 134: 119-38. PMID 15790536 DOI: 10.1016/j.molbrainres.2004.10.003 |
0.475 |
|
| 2005 |
Wang Q, Woltjer RL, Cimino PJ, Pan C, Montine KS, Zhang J, Montine TJ. Proteomic analysis of neurofibrillary tangles in Alzheimer disease identifies GAPDH as a detergent-insoluble paired helical filament tau binding protein. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 19: 869-71. PMID 15746184 DOI: 10.1096/Fj.04-3210Fje |
0.685 |
|
| 2005 |
Zaja-Milatovic S, Milatovic D, Schantz AM, Zhang J, Montine KS, Samii A, Deutch AY, Montine TJ. Dendritic degeneration in neostriatal medium spiny neurons in Parkinson disease. Neurology. 64: 545-7. PMID 15699393 DOI: 10.1212/01.Wnl.0000150591.33787.A4 |
0.567 |
|
| 2005 |
Zhang J, Goodlett DR, Peskind ER, Quinn JF, Zhou Y, Wang Q, Pan C, Yi E, Eng J, Aebersold RH, Montine TJ. Quantitative proteomic analysis of age-related changes in human cerebrospinal fluid. Neurobiology of Aging. 26: 207-27. PMID 15582749 DOI: 10.1016/J.Neurobiolaging.2004.03.012 |
0.521 |
|
| 2004 |
Zhou Y, Shie FS, Piccardo P, Montine TJ, Zhang J. Proteasomal inhibition induced by manganese ethylene-bis-dithiocarbamate: relevance to Parkinson's disease. Neuroscience. 128: 281-91. PMID 15350641 DOI: 10.1016/J.Neuroscience.2004.06.048 |
0.574 |
|
| 2004 |
Zhou Y, Gu G, Goodlett DR, Zhang T, Pan C, Montine TJ, Montine KS, Aebersold RH, Zhang J. Analysis of alpha-synuclein-associated proteins by quantitative proteomics. The Journal of Biological Chemistry. 279: 39155-64. PMID 15234983 DOI: 10.1074/Jbc.M405456200 |
0.506 |
|
| 2004 |
Zhang J, Goodlett DR. Proteomic approach to studying Parkinson's disease. Molecular Neurobiology. 29: 271-88. PMID 15181239 DOI: 10.1385/MN:29:3:271 |
0.423 |
|
| 2004 |
Montine KS, Quinn JF, Zhang J, Fessel JP, Roberts LJ, Morrow JD, Montine TJ. Isoprostanes and related products of lipid peroxidation in neurodegenerative diseases. Chemistry and Physics of Lipids. 128: 117-24. PMID 15037157 DOI: 10.1016/J.Chemphyslip.2003.10.010 |
0.572 |
|
| 2003 |
Gu G, Deutch AY, Franklin J, Levy S, Wallace DC, Zhang J. Profiling genes related to mitochondrial function in mice treated with N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Biochemical and Biophysical Research Communications. 308: 197-205. PMID 12890501 DOI: 10.1016/S0006-291X(03)01233-6 |
0.331 |
|
| 2003 |
Fessel JP, Hulette C, Powell S, Roberts LJ, Zhang J. Isofurans, but not F2-isoprostanes, are increased in the substantia nigra of patients with Parkinson's disease and with dementia with Lewy body disease. Journal of Neurochemistry. 85: 645-50. PMID 12694390 DOI: 10.1046/J.1471-4159.2003.01709.X |
0.451 |
|
| 2003 |
Zhang J, Fitsanakis VA, Gu G, Jing D, Ao M, Amarnath V, Montine TJ. Manganese ethylene-bis-dithiocarbamate and selective dopaminergic neurodegeneration in rat: a link through mitochondrial dysfunction. Journal of Neurochemistry. 84: 336-46. PMID 12558996 DOI: 10.1046/J.1471-4159.2003.01525.X |
0.766 |
|
| 2002 |
Gu G, Reyes PE, Golden GT, Woltjer RL, Hulette C, Montine TJ, Zhang J. Mitochondrial DNA deletions/rearrangements in parkinson disease and related neurodegenerative disorders. Journal of Neuropathology and Experimental Neurology. 61: 634-9. PMID 12125742 DOI: 10.1093/Jnen/61.7.634 |
0.536 |
|
| 2002 |
Zhang J, Montine TJ, Smith MA, Siedlak SL, Gu G, Robertson D, Perry G. The mitochondrial common deletion in Parkinson's disease and related movement disorders. Parkinsonism & Related Disorders. 8: 165-70. PMID 12039426 DOI: 10.1016/S1353-8020(01)00041-4 |
0.557 |
|
| 2000 |
Zhang J, Graham DG, Montine TJ, Ho YS. Enhanced N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity in mice deficient in CuZn-superoxide dismutase or glutathione peroxidase. Journal of Neuropathology and Experimental Neurology. 59: 53-61. PMID 10744035 DOI: 10.1093/Jnen/59.1.53 |
0.504 |
|
| 2000 |
Zhang J, Kravtsov V, Amarnath V, Picklo MJ, Graham DG, Montine TJ. Enhancement of dopaminergic neurotoxicity by the mercapturate of dopamine: relevance to Parkinson's disease. Journal of Neurochemistry. 74: 970-8. PMID 10693927 DOI: 10.1046/J.1471-4159.2000.0740970.X |
0.508 |
|
| 1999 |
Picklo MJ, Zhang J, Nguyen VQ, Graham DG, Montine TJ. High-pressure liquid chromatography quantitation of cytochrome c using 393 nm detection. Analytical Biochemistry. 276: 166-70. PMID 10603239 DOI: 10.1006/Abio.1999.4349 |
0.412 |
|
| 1999 |
Zhang J, Perry G, Smith MA, Robertson D, Olson SJ, Graham DG, Montine TJ. Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons. The American Journal of Pathology. 154: 1423-9. PMID 10329595 DOI: 10.1016/S0002-9440(10)65396-5 |
0.551 |
|
| 1998 |
Zhang J, Price JO, Graham DG, Montine TJ. Secondary excitotoxicity contributes to dopamine-induced apoptosis of dopaminergic neuronal cultures. Biochemical and Biophysical Research Communications. 248: 812-6. PMID 9704010 DOI: 10.1006/Bbrc.1998.9044 |
0.455 |
|
| 1998 |
Zhang J, Price JO, Graham DG, Montine TJ. EXCITOTOXICITY CONTRIBUTES TO DOPAMINE-INDUCED APOPTOSIS OF DOPAMINERGIC NEURONAL CULTURES Journal of Neuropathology and Experimental Neurology. 57: 510. DOI: 10.1097/00005072-199805000-00182 |
0.436 |
|
| Show low-probability matches. |